良性阵发性位置性眩晕手法复位后残余症状的相关因素分析

Analysis of Related Factors of Residual Symptom after Manipulative Reduction of Benign Paroxysmal Positional Vertigo

张姝;徐凌;高伟;崔晓波;

1:内蒙古医科大学附属医院耳鼻咽喉科

摘要
目的探讨良性阵发性位置性眩晕(benign paroxysmal positional vertigo,BPPV)手法复位后残余症状的发生率及相关危险因素。方法 2017年3月至2018年3月确诊为BPPV并实施手法复位治疗的210例患者,根据治疗后有无残余症状分为有残余症状组和无残余症状组,分析残余症状的出现率及相关危险因素。结果本组210例BPPV患者除2例退出研究外,复位后残余症状的出现率为58.10%(122/210);单因素分析结果显示,发病月份、焦虑状态、伴糖尿病、伴高血压、血清25(OH)D_3浓度水平、复位次数、发病类型、血清半胱氨酸水平是出现残余症状的危险因素;多因素Logistics回归分析结果显示,发病月份、伴糖尿病、伴高血压、血清25(OH)D_3浓度水平、复位次数、发病类型、血清半胱氨酸水平是发生残余症状的危险因素。12~2月发病者血清25(OH)D_3浓度低于其他月份发病者。管结石症患者的血清25(OH)D_3水平低于嵴顶结石症患者。结论本组BPPV患者手法复位后残余症状的出现与发病月份、伴糖尿病和高血压、血清25(OH)D_3水平、血清半胱氨酸水平、发病类型及复位次数有关。
关键词
良性阵发性位置性眩晕;残余症状;手法复位
基金项目(Foundation):
作者
张姝;徐凌;高伟;崔晓波;
参考文献

1 Nguyen-Huynh AT.Evidence-based practice:management of vertigo[J].Otolaryngol Clin North Am,2012,45:925.

2 Walther LE.Procedures for restoring vestibular disorderal[J].GMS Curr Top Otorhinolaryngol Head Neck Surg,2005,4:5.

3 Teggi R,Giordano L,Bondi S,et al.Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo in the elderly [J].Eur Arch Otorhinolaryngol,2011,268:507.

4 Teggi R,Giordano L,Bondi S,et al.Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo in the elderly[J].Eur Arch Otorhinolaryngol,2011,268:207.

5 刘晓薇,孙敬武,张波,等.良性阵发性位置性眩晕成功复位后残余头晕的危险因素分析[J].听力学及言语疾病杂志,2018,26:148.

6 Bhattaeharyya N,Reginald F,Baugh F,et al.Clinical practice guideline:Benign paroxysmal positional vertigo[J].Otolaryngology Head Neck Surg,2008,139(5 Suppl4):47.

7 Seok JI,Lee HM,Yoo JH,et al.Residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo[J].J Clin Neurol,2008,4:107.

8 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉科学分会.良性阵发性位置性眩晕的诊断与治疗指南[J].中华耳鼻咽喉头颈外科杂志,2017,52:173.

9 张作记.行为医学量表手册[M].北京:中华医学电子音像出版社,2005.213~223.

10 Sharpley CF,Christh IE DR.Ananalys is of the psychometric Profile and frequency of anxiety and depression in Australian men with prostate cancer[J].Psychoon Cology,2007,16:660.

11 刘贤臣,唐茂芹,胡蕾,等.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29:103.

12 闫亚平,张淑香.特发性良性阵发性位置性眩晕发病危险因素研究进展[J].中国中西医结合耳鼻咽喉科杂志,2017,25:392.

13 Vrane?i■ Bender D,Giljevi■ Z,Ku?ec V,et al.Guidelines for the prevention,detection and therapy of vitamin D deficiency in adults[J].Lije■ Vjesn,2016,138:1.

14 Micarelli A,Viziano A,Alessandrini M.A comprehensive insight into the rehabilitative treatment of persistentbenign paroxysmal positional vertigo[J].J Int Adv Otol,2017,13:147.

15 Kim HA,Lee H.Autonomic dysfunction as a possible cause of residual dizziness after successful treatment in benign paroxysmal positional vertigo[J].Clinical Neurophysiology,2014,125:608.

16 Farally M,Lapenna R,Giommetti G,et al.Residual dizziness after the first BPPV episode:role of otolithic function and of a delayed diagnosis[J].Eur Arch Otorhinolaryngol,2016,273:3157.

17 Faralli M,Manzari L,Panichi R,et al.Subjective visual vertical before and after treatment of a BPPV episode[J].Auris Nasus Larynx,2011,38:307.

18 李斐,肖本杰,陈瑛,等.良性阵发性位置性眩晕复位后残余症状持续时间和病因分析[J].第二军医大学学报,2018,2:216.

19 胡进,傅伟达,尤克,等.继发性和原发性良性发作性位置性眩晕残余头晕症状的比较[J].中华全科医学,2017,10:1694.

20 D'Silva LJ,Staecker H,Lin J,et al.Retrospective data suggests that the higher prevalence of benign paroxysmal positional vertigo in individuals with type 2 diabetes is mediated by hypertension[J].J Vestib Res,2016,25:233.

21 Martellucci S,Pagliuca G,de Vincentiis M,et al.Features of residual dizziness after canalith repositioning procedures for benign paroxysmal positional vertigo[J].Otolaryngology-Head and Neck Surgery,2016,154:693.

22 Chen ZJ,Chang CH,Hu LY,et al.Increased risk ofbenign paroxysmal positional vertigoin patients with anxiety disorders:a nationwide population-based retrospective cohort study[J].BMC Psychiatry,2016,16:238.

23 于新军,孙宝梅.良性阵发性位置性眩晕病因学研究[J].北京医学,2017,8:770.

24 岳伟,相蕾,张雅静,等.老年人良性阵发性位置性眩晕与颅内外血管病变的关系[J].中华老年医学杂志,2014,33:355.

25 De Stefano A,Dispenza F,Suarez H,et al.A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo[J].Auris Nasus Larynx,2014,41:31.

26 Celikbilek A,Gencer ZK,Saydam L,et al.Serum uric acid levels correlate with benign paroxysmal positional vertigo[J].Eur J Neurol,2014,21:79.

27 刘韵,王伟,龚树生.310例良性阵发性位置性眩晕患者发病相关因素分析[J].临床耳鼻咽喉头颈外科杂志,2016,9:748.

28 Sheikhzadeh M,Lotfi Y,Mousavi A,et al.Influence of supplemental Vitamin D on intensity of benign paroxysmal plsitional vertigo:a longitudinal clinical study[J].Caspian J Intern Med,2016,7:93.

29 Talaat HS,Kabel AM,Khaliel LH,et al.Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency[J].Auris Nasus Larynx,2016,43:237.

30 顾湘,董飞林,顾建华.良性阵发性位置性眩晕患者血清25羟维生素D水平研究[J].临床耳鼻咽喉头颈外科杂志,2017,31:924.

31 Maslovara S,Sollos B,Sestak A,et al.25(OH)D3 levels,in cideme and recurrence of different clinical forms of BPPV[J].Braz Otorhin Olarungol,2017,5:1.

32 贾永林,付志新,张宝华.良性发作性位置性眩晕手法复位后残余症状分析[J].中国实用神经疾病杂志,2017,20:12.

33 Gacek RR,Gacek MR.The three faces of vestibular ganglionitis[J].Ann Otol Rhinol Laryngol,2002,111:103.

34 Zapala DA,Shapiro SA,Lundy LB,et al.Simultaneous acute superior nerve neuronitis and benign paroxysmal positional vertigo[J].J Am Acad Audiol,2006,17:482.

本文信息

PDF(155K)

本文作者相关文章

张姝徐凌高伟崔晓波